Featured Research

from universities, journals, and other organizations

New AIDS Vaccine Approach Aims to Catch Virus in the Act

Date:

January 20, 1999

Source:

Howard Hughes Medical Institute

Summary:

A novel approach to producing antibodies against the AIDS virus has proven effective against a wide range of HIV strains, raising the hope that a broadly effective vaccine is possible. The new approach generates immune system antibodies against the infective proteins of the virus while the virus is fusing with a target cell.

Share This

January 15, 1999 — A novel approach to producing antibodies against the AIDS virus has proven effective against a wide range of HIV strains, raising the hope that a broadly effective vaccine is possible. The new approach generates immune system antibodies against the infective proteins of the virus while the virus is fusing with a target cell.

Related Articles

Scientists from the University of Montana and the Howard Hughes Medical Institute (HHMI) at New York University Medical Center sought to "freeze" the AIDS viral machinery in the act of contorting itself to fuse with its target cell. The investigators believed that this transition stage in the infective process exposes immune-triggering molecules that the virus normally keeps hidden within the depths of its structure.

The scientists' success at producing broadly effective antibodies against HIV is in sharp contrast to previous efforts, in which the resulting antibodies neutralized laboratory-grown HIV strains, but not "primary isolates," strains of the virus found in AIDS patients.

Reporting the new findings in the January 15, 1999, issue of the journal Science are University of Montana researchers Jack Nunberg, Rachel LaCasse, Kathryn Follis and Meg Trahey; and Dan Littman and John Scarborough of HHMI at New York University Medical Center.

"Perhaps to the surprise of all involved, this ambitious experiment worked," wrote AIDS researchers David Montefiori and John Moore in a commentary on this work that was also published in the January 15 issue of Science. "The mouse sera, and antibodies purified from them, inhibited the infectivity of an impressive array of diverse HIV-1 primary isolates, including viruses from multiple genetic subtypes." Montefiori is at Duke University Medical Center, and Moore is at The Rockefeller University.

Nunberg and his colleagues began by constructing a molecular facsimile of the AIDS infective machinery and of the receptors to which it binds on surface of host cells.

They first genetically engineered monkey cells to produce the HIV surface, or envelope, molecules that are responsible for grabbing onto human cells in the infective process. These surface molecules are called glycoproteins. The researchers then mixed these monkey cells with human cells whose surface was festooned with the receptors that HIV latches onto in infecting cells.

The scientists "froze" the combined cells in the act of fusing by treating them with a weak solution of formaldehyde, which forged a web of chemical links that trapped the molecules in place.

The researchers then injected this mixture, which they dubbed a "fusion-competent immunogen," into mice that Littman's team had genetically engineered to also produce the human receptors. Littman's group had developed the mice specifically to serve as models for HIV vaccine development. Using such mice for immunization was necessary to avoid having the animals' immune system react to the foreign human receptors, rather than to the HIV machinery.

Finally, the Montana scientists isolated an antibody-rich blood serum from the immunized mice. They tested this serum's effectiveness against HIV by mixing it with a diverse collection of viruses isolated from infected humans. The researchers discovered that the antibodies effectively neutralized every one of the many different strains of HIV.

"I think it's a very, very encouraging development," says Littman. "Until now, it has been very difficult to generate antibodies against HIV envelope glycoprotein that are broadly reactive. This is really the first example of being able to somehow trick the immune system into making broadly neutralizing antibodies that are presumably active against the HIV envelope glycoprotein."

Nunberg, Littman and their colleagues emphasize that while the new approach is highly promising, much work remains for the method to prove useful in a vaccine for humans. For one thing, they said, injection of whole live cells into humans is not practical in terms of vaccine safety or durability.

Rather, said Littman, a vaccine will likely depend on isolating the specific glycoprotein that triggers response to HIV and producing it using recombinant DNA technology. "Based on this advance, however, I think there is a good possibility that we'll be able to mimic the immunogenic properties of fusion-competent envelopes on cells by instead using recombinant proteins," he said.

The scientists also said it will be important to determine whether the antibodies they generated in mice can also be generated in primates and, eventually, in humans.

More From ScienceDaily

More Health & Medicine News

Featured Research

Mar. 3, 2015 — Scientists have discovered a new hormone that fights the weight gain caused by a high-fat Western diet and normalizes the metabolism -- effects commonly associated with exercising. When tested in ... full story

Mar. 3, 2015 — New assays can detect malaria parasites in human blood at very low levels and might be helpful in the campaign to eradicate malaria, reports a new study. An international team led by Ingrid Felger, ... full story

Mar. 3, 2015 — Adults over the age of 30 only catch flu about twice a decade, a new study suggests. So, while it may feel like more, flu-like illness can be caused by many pathogens, making it difficult to assess ... full story

Mar. 3, 2015 — No significant change in home habits of smokers have been observed in the aftermath of a ban on smoking in public spaces, researchers report. Greater inspiration to kick the habit likely comes from ... full story

Mar. 3, 2015 — Heart function has been associated with the development of dementia and Alzheimer's disease through a new study. Participants with decreased heart function, measured by cardiac index, were two to ... full story

Mar. 3, 2015 — Children of recently separated or divorced families are likelier to drink sugar-sweetened beverages than children in families where the parents are married, putting them at higher risk for obesity ... full story

Mar. 3, 2015 — Gastric bypass and similar stomach-shrinking surgeries are a popular option for obese patients looking to lose weight or treat type 2 diabetes. While the surgeries have been linked to a decreased ... full story

Mar. 3, 2015 — Most people consume more salt than they need and therefore have a higher risk of heart disease and stroke, which are the two leading causes of death worldwide. But a new study reveals that dietary ... full story

Featured Videos

Mom Triumphs Over Tragedy, Helps Other Families

AP (Mar. 3, 2015) — After her son, Dax, died from a rare form of leukemia, Julie Locke decided to give back to the doctors at St. Jude Children&apos;s Research Hospital who tried to save his life. She raised $1.6M to help other patients and their families. (March 3)
Video provided by AP

Looted and Leaking, South Sudan's Oil Wells Pose Health Risk

AFP (Mar. 3, 2015) — Thick black puddles and a looted, leaking ruin are all that remain of the Thar Jath oil treatment facility, once a crucial part of South Sudan&apos;s mainstay industry. Duration: 01:13
Video provided by AFP

Woman Convicted of Poisoning Son

AP (Mar. 3, 2015) — A woman who blogged for years about her son&apos;s constant health woes was convicted Monday of poisoning him to death by force-feeding heavy concentrations of sodium through his stomach tube. (March 3)
Video provided by AP

Related Stories

Sep. 3, 2014 — A new vulnerability has been discovered in the armor of HIV that a vaccine, other preventive regimen or treatment could exploit. The site straddles two proteins, gp41 and gp120, that jut out of the ... full story

July 24, 2014 — Scientists have found an immunologic mechanism that makes broadly neutralizing antibodies in people who are HIV-1 infected. The research team found that two distinct B-cell lineage antibodies teamed ... full story

June 24, 2014 — Huge advancements have taken place in HIV treatment and prevention over the past 10 years, but there is still no cure or vaccine. A new review shows that because of advancements in treatment, people ... full story

Nov. 23, 2011 — HIV is coated in sugars that usually hide the virus from the immune system. Newly published research reveals how one broadly neutralizing HIV antibody actually uses part of the sugary cloak to help ... full story

ScienceDaily features breaking news and videos about the latest discoveries in health, technology, the environment, and more -- from major news services and leading universities, scientific journals, and research organizations.